PyInvesting

Market research

UTMD Utah Medical Products Inc

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
228M
P/E ratio
21.84
Analyst target
Not available
Dividend yield
1.7%
Beta
0.36

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Utah Medical Products, Inc is currently in a long term downtrend where the price is trading 1.2% below its 200 day moving average.

From a valuation standpoint, the stock is 99.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.7.

Utah Medical Products, Inc's total revenue rose by 1.5% to $12M since the same quarter in the previous year.

Its net income has dropped by 21.7% to $3M since the same quarter in the previous year.

Finally, its free cash flow fell by 369.3% to $-14M since the same quarter in the previous year.

Based on the above factors, Utah Medical Products, Inc gets an overall score of 2/5.